Navigation Links
FDA Approves First Drug to Prevent Premature Births
Date:2/7/2011

those women."

Hydroxyprogesterone caproate has not been without some controversy. In 2006, an FDA advisory committee considering hydroxyprogesterone caproate to treat preterm birth brought up safety concerns, including a possible association with second trimester miscarriages.

Hydroxyprogesterone caproate is also the same drug as a much older one called Delalutin, which was approved by the FDA in 1956 and was used to treat female hormone disturbances and cancer, but withdrawn from the market for business reasons in 2008, the agency says.

"Makena is chemically the same as Delalutin," Burgess said.

What is new here is that a drug company will be making the drug; it won't have to be made up in pharmacies, according to Fleischman. "There will be consistency and high quality. This makes it a breakthrough not only that it's FDA approved and doctors will be comfortable in recommending it, but also there will be high quality and consistency for women as they take it," he said.

Dr. Gene Burkett, a professor of obstetrics and gynecology at the University of Miami Miller School of Medicine said that "this is something we have been using with women prone to preterm labor. It has been almost a standard of care for the last five or six years."

"Makena was approved under FDA's accelerated approval regulations, which allow promising drugs to be approved based on showing a benefit on a 'surrogate endpoint' that is likely to predict an actual clinical benefit," Burgess said. In this case, it was reducing the risk of delivery before 37 weeks.

Part of the terms of this approval require the manufacturer to conduct studies that demonstrate that the drug has a clinical benefit, she said.

In making its decision, the FDA reviewed data on the safety and effectiveness of Makena from a clinical trial that included 463 pregnant women who had a history of a spontaneous preterm birth.

Among those receiving Makena, 37 percent delivered be
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Swiss agency approves clinical trial of UCI-created neural stem cell therapy
2. ACGME board approves final duty hour and supervision standards for resident education
3. FDA Approves 1st Oral Drug to Reduce MS Relapses
4. FDA approves Merz Pharmaceuticals Xeomin (incobotulinumtoxinA) for the treatment of cervical dystonia and blepharospasm
5. Early detection of cancer: The FDA approves procedure discovered by EPFL researchers
6. FDA approves first human neural stem cell clinical trial to treat brain tumors
7. FDA Approves Stemedica IND for Ischemic Stroke Clinical Trial
8. New York State Office of Mental Health Approves New High Performance Polycarbonate Sheet for Use in All Facilities
9. House of Representatives Approves Health-Care Reform Bill
10. Congress Approves Bill Curbing Internet Tobacco Sales in Victory for Kids and Taxpayers
11. New Jersey Approves Initiative to Expand the Number of Wound Care Certified Professionals
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Approves First Drug to Prevent Premature Births 
(Date:5/22/2015)... ZH Healthcare (ZH), ... today that Bill Lane, joins ZH’s Advisory Board. ... BlueEHS,a first of its kind, Freemium SaaS, Electronic ... Health Records (EHR) with an integrated practice management ... patient portal, and more. Combined with its Revenue ...
(Date:5/22/2015)... 22, 2015 Medivo, Inc., a leader in ... and Genotype Results in ‘Baby Boomers’ Screened for HCV Following ... Lab Test Database” at Digestive Disease Week, May 16-19, 2015. ... and Analytics team members Carol Smyth, MB; Jason Bhan, MD; ... MSI, along with Nancy Reau, MD from the University of ...
(Date:5/22/2015)... DMG Productions announces the upcoming airing ... on Friday, May 29, 2015 at 7:30 a.m. ET ... this episode Innovations will explore Interstate Restoration, a company ... through disaster recovery and restoration. , Additionally, the series ... to develop and deliver training and education in the ...
(Date:5/22/2015)... May 22, 2015 In April 2006, ... the past 9 years they have concentrated their focus ... States and Canada. Because of this growth and their ... corporate offices in Denver, Colorado, Cleveland, Ohio, Houston, Texas ... in opening new dental offices, dental start ups, orthodontic ...
(Date:5/22/2015)... 2015 Puritan Medical Products, a ... medical, diagnostic, environmental, and forensics industries celebrates 96 ... in the US. At a time when countless ... US, Puritan remains committed to designing and manufacturing ... Maine facility. , Since 1919, Puritan has focused ...
Breaking Medicine News(10 mins):Health News:ZH Healthcare Adds Bill Lane to Advisory Board 2Health News:Medivo Study Finds HCV Positivity Rates are 250% Higher Among Baby Boomers 2Health News:New Episode of Innovations Airing Friday, May 29, 2015 Via Discovery Channel 2Health News:Maine Swab Company Celebrates 96 Years of American-made Products 2
... ... Essay Contest, Contest will reward winning caregivers with ... for a break for,America,s unsung heroes, the 50 million American caregivers who ... Number One resource for family caregivers., That,s why Caring Today magazine ...
... Political Accountability Major Part of Unprecedented ,Justice for,All, Plan ... than $150 million, mobilize tens of,thousands during and AFTER ... WASHINGTON, May 8 Members and leaders of ... hold elected,leaders strictly accountable if they say one thing ...
... to ease condition in water creature , , THURSDAY, May 8 ... Iraq War veterans, ringing in the ears is a condition ... Now, a researcher says he hopes to find a cure ... Moore, an audiologist and cell biologist at Northwestern University, said ...
... As injectable fillers,become mainstream it is no ... expensive alternatives to prevent facial wrinkles. Dr. Arnold,Klein, ... Hills says, "Fillers such as Artefill, Radiesse and ... injected into,human tissue, all of these products can ...
... The following is being,issued by the National Kidney Foundation ... including headlining sets from Staind and Live, as,well as ... of DC,101,s Last Band Standing Contest, The Blackjacks; top ... judges including America,s Next,Top Model finalist Sara Albert., ...
... Easily Detected and ... Treated, ... CEO of Susan G. Komen for the Cure(R),testified today before a special ... need for comprehensive legislation to,address the nation,s cancer crisis., (Logo: ...
Cached Medicine News:Health News:Do You Need a Caregiving Break Today? 2Health News:Do You Need a Caregiving Break Today? 3Health News:SEIU Members to Politicians: Live Up to Your Promises or We Will Hold You Accountable 2Health News:SEIU Members to Politicians: Live Up to Your Promises or We Will Hold You Accountable 3Health News:SEIU Members to Politicians: Live Up to Your Promises or We Will Hold You Accountable 4Health News:Secret to Treating Tinnitus in Vets May Be Unlocked in Zebrafish 2Health News:Dr. Arnold Klein Warns of Dangers With Permanent and Longer Lasting Injectable Fillers 2Health News:Susan G. Komen for the Cure's(R) Moddelmog Calls for Congress to Launch Colossal Cancer Crusade 2Health News:Susan G. Komen for the Cure's(R) Moddelmog Calls for Congress to Launch Colossal Cancer Crusade 3
(Date:5/22/2015)... May 22, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX), ... repair and regeneration, today announced that J.J. Finkelstein ... present a corporate overview at two upcoming investor conferences. ... SeeThruEquity 4 th Annual Microcap Conference on Thursday ... at 11:00 am EDT.  A webcast will ...
(Date:5/22/2015)... , May 22, 2015  The Mesothelioma ... diagnosed victims of mesothelioma get the best possible ... certain individuals with this rare cancer caused by ... most up-to-date information related to treatment options such ... please call the Mesothelioma Victims Center anytime at ...
(Date:5/22/2015)... May 22, 2015 Research and Markets ... of the "Latest Regulations on Pharmaceutical International ... their offering. This is first time ... guidance on international multi-center clinical trials of drugs ... begun to be implemented on March 1, 2015. ...
Breaking Medicine Technology:RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 52015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: